Thermal Stability of RNA Phage Virus-Like Particles Displaying Foreign Peptides
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-3155
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Thermal Stability of RNA Phage Virus-Like Particles Displaying Foreign Peptides ; volume:9 ; number:1 ; day:24 ; month:5 ; year:2011 ; pages:1-7 ; date:12.2011
Journal of nanobiotechnology ; 9, Heft 1 (24.5.2011), 1-7, 12.2011
- Urheber
-
Caldeira, Jerri C.
- Beteiligte Personen und Organisationen
-
Peabody, David S.
SpringerLink (Online service)
- DOI
-
10.1186/1477-3155-9-22
- URN
-
urn:nbn:de:1111-2016073039353
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Caldeira, Jerri C.
- Peabody, David S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Displaying the prion protein on virus-like particles : a novel tool towards vaccination
Displaying the prion protein on virus-like particles : a novel tool towards vaccination
Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers
Evaluation of antigen-displaying adeno-associated virus-like particles (AAVLPs) as future candidates for personalized cancer vaccination
Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
Development of target antigen-displaying virus-like particles (VLPs) for the generation of antibodies using hybridoma technology
Virus-like particles displaying conserved toxin epitopes stimulate polyspecific, murine antibody responses capable of snake venom recognition
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
Ebola virus–like particles reprogram cellular metabolism
Expression of human papillomavirus 6b L1 protein in silkworm larvae and enhanced green fluorescent protein displaying on its virus-like particles
Identification of gliadin-binding peptides by phage display
Characterization and quantitation of fluorescent Gag virus-like particles
Displaying the prion protein on virus-like particles : a novel tool towards vaccination
Displaying the prion protein on virus-like particles : a novel tool towards vaccination
Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers
Evaluation of antigen-displaying adeno-associated virus-like particles (AAVLPs) as future candidates for personalized cancer vaccination
Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
Development of target antigen-displaying virus-like particles (VLPs) for the generation of antibodies using hybridoma technology
Virus-like particles displaying conserved toxin epitopes stimulate polyspecific, murine antibody responses capable of snake venom recognition
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
Ebola virus–like particles reprogram cellular metabolism
Expression of human papillomavirus 6b L1 protein in silkworm larvae and enhanced green fluorescent protein displaying on its virus-like particles
Identification of gliadin-binding peptides by phage display
Characterization and quantitation of fluorescent Gag virus-like particles
Displaying the prion protein on virus-like particles : a novel tool towards vaccination
Displaying the prion protein on virus-like particles : a novel tool towards vaccination
Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers
Evaluation of antigen-displaying adeno-associated virus-like particles (AAVLPs) as future candidates for personalized cancer vaccination
Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
Development of target antigen-displaying virus-like particles (VLPs) for the generation of antibodies using hybridoma technology
Virus-like particles displaying conserved toxin epitopes stimulate polyspecific, murine antibody responses capable of snake venom recognition
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
Ebola virus–like particles reprogram cellular metabolism
Expression of human papillomavirus 6b L1 protein in silkworm larvae and enhanced green fluorescent protein displaying on its virus-like particles
Identification of gliadin-binding peptides by phage display